Mitigation of pandemic influenza: review of cost-effectiveness studies
- PMID: 19941432
- DOI: 10.1586/erp.09.56
Mitigation of pandemic influenza: review of cost-effectiveness studies
Abstract
We conducted a review of economic evaluations of pandemic influenza control measures. In the studies found, we detected various interventions being investigated: antiviral stockpiling and treatment, prophylaxis, vaccination, school closure and restricting international travel. Cost-effectiveness varied but often showed potentials for the favorable economic profiles of these measures. Both static and dynamic models were used. We conclude that the choice of an appropriate model - in particular, a dynamic model - is crucial to arrive at valid cost-effectiveness ratios. Yet, of the economic evaluations considered here, only a few were based on dynamic modeling. We recommend that further research is directed toward linking dynamic epidemiological models for pandemic spread with economic outcomes by considering the full impacts on national economies, including direct, indirect, medical and nonmedical costs.
Similar articles
-
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.Expert Rev Anti Infect Ther. 2010 Dec;8(12):1431-9. doi: 10.1586/eri.10.136. Expert Rev Anti Infect Ther. 2010. PMID: 21133667 Review.
-
[Cost-effectiveness of prophylaxis and treatment of influenza].Dtsch Med Wochenschr. 2003 Oct 24;128(43):2267-70. doi: 10.1055/s-2003-43100. Dtsch Med Wochenschr. 2003. PMID: 14574642 German. No abstract available.
-
Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.Health Econ. 2010 May;19(5):518-31. doi: 10.1002/hec.1485. Health Econ. 2010. PMID: 19382106
-
Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.J Am Geriatr Soc. 2005 Mar;53(3):444-51. doi: 10.1111/j.1532-5415.2005.53162.x. J Am Geriatr Soc. 2005. PMID: 15743287
-
[The use of antiviral agents during an (impending) influenza pandemic].Ned Tijdschr Geneeskd. 2007 May 5;151(18):1008-12. Ned Tijdschr Geneeskd. 2007. PMID: 17508684 Review. Dutch.
Cited by
-
Identifying the relative priorities of subpopulations for containing infectious disease spread.PLoS One. 2013 Jun 12;8(6):e65271. doi: 10.1371/journal.pone.0065271. Print 2013. PLoS One. 2013. PMID: 23776461 Free PMC article.
-
Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives.PLoS Comput Biol. 2011 Feb 10;7(2):e1001076. doi: 10.1371/journal.pcbi.1001076. PLoS Comput Biol. 2011. PMID: 21347316 Free PMC article.
-
Buy now, saved later? The critical impact of time-to-pandemic uncertainty on pandemic cost-effectiveness analyses.Health Policy Plan. 2015 Feb;30(1):100-10. doi: 10.1093/heapol/czt101. Epub 2013 Dec 24. Health Policy Plan. 2015. PMID: 24369125 Free PMC article.
-
A Bayes Decision Rule to Assist Policymakers during a Pandemic.Healthcare (Basel). 2021 Aug 9;9(8):1023. doi: 10.3390/healthcare9081023. Healthcare (Basel). 2021. PMID: 34442160 Free PMC article.
-
The role of economic evaluation in modelling public health and social measures for pandemic policy: a systematic review.Cost Eff Resour Alloc. 2024 Nov 1;22(1):77. doi: 10.1186/s12962-024-00585-6. Cost Eff Resour Alloc. 2024. PMID: 39487485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical